Farms.com Home   News

DOT Technology Sells To Raven Industries

DOT’s inventor Norbert Beaujot says it all started as SeedMaster looked at the idea of doing an autonomous seeder when he developed the u-shaped power platform to move it.

The idea and design took off and they began manufacturing.

This year they’ll have about 10 units out on-farm this spring across Western Canada.

He notes DOT was his baby and it was a tough decision to sell.

“We got it to the stage of proof of concept stage and testing stage, that we know it’ll work. It’ll do a lot for farmers, and really, it takes a larger company to take it forward from here on.”

Wade Robey, Executive Director of Raven Autonomy and General Manager of Dot, says they expect to see interest in the unit continue to grow.

“This year we hope to sell somewhere around 25 units with them principally going to Western Canada, across a range of different applications this year. So, currently, we have a seeder, a spreader, and a sprayer that are approved implements for DOT; and we're working on a couple of other implements that we'd like to have ready to go by the end of the year.”

He believes autonomous equipment can help address the labor shortage issue in the agriculture sector.

“This isn't just a situation that affects North America, as we talk to partners in South Africa and Australia, in Latin America. They're having tremendous issues with labor, not just labor accessibility but the education or the capability of that labor to do what are very sophisticated jobs on farm, and to operate what are very sophisticated pieces of machinery.”

Robey thinks with automation we’ll see a tremendous opportunity to optimize production, improve the efficiency of farming, and reduce the cost of farming.

Raven Industries will continue to manufacture DOT in Saskatchewan with SeedMaster.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.